TABLE IV.
Changes in Pain and Function After GAE
| Outcome and Time | Score Change from Baseline* | Percent Change from Baseline* |
|---|---|---|
| VAS pain | ||
| Month 1 | −4.5 (−9 to 2) | −60.20 (−100 to 33.33) |
| Month 3 | −4.5 (−10 to 2) | −60.20 (−100 to 33.33) |
| Month 6 | −5.0 (−8.5 to −1) | −62.50 (−100 to −10) |
| Month 12 | −5.0 (−9 to 0) | −66.67 (−100 to 0) |
| WOMAC pain | ||
| Month 1 | −6.0 (−17 to 3) | −54.70 (−100 to 60) |
| Month 3 | −7 (−15 to 6) | −59.94 (−100 to 100) |
| Month 6 | −7 (−14 to 6) | −62.50 (−100 to100) |
| Month 12 | −7.5 (−14 to 6) | −65.69 (−100 to 100) |
| WOMAC total | ||
| Month 1 | −20.5 (−71 to 20) | −55.26 (−96 to 40) |
| Month 3 | −29.5 (−74 to 26) | −64.84 (−98 to 54) |
| Month 6 | −26.50 (−81 to 19) | −58.11 (−100 to 54) |
| Month 12 | −29.00 (−82 to19) | −60.54 (−100 to 54) |
*
The values are given as the median, with the range in parentheses.